US20825C1045 - Common Stock
2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue YoY % growth | 45.828B 143.97% | 78.494B 71.28% | 56.141B -28.48% | 59.217B 5.48% | N/A | N/A | N/A | ||||
EBITDA YoY % growth | 19.466B 354.39% | 32.91B 69.06% | 23.137B -29.70% | 25.9B 11.94% | N/A | N/A | |||||
EBIT YoY % growth | 12.258B 1,090.95% | 25.406B 107.26% | 14.867B -41.48% | 16.785B 12.90% | N/A | N/A | N/A | ||||
Operating Margin | 26.75% | 32.37% | 26.48% | 28.34% | N/A | N/A | N/A | ||||
EPS YoY % growth | 6.00 718.56% | 13.49 124.83% | 8.78 -34.91% | 8.83 0.57% |
All data in USD
Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS Q2Q % growth | 2.06 -13.48% | |||||||||||
Revenue Q2Q % growth | 15.101B 1.96% | |||||||||||
EBITDA Q2Q % growth | 6.329B | |||||||||||
EBIT Q2Q % growth | 3.847B -6.94% |
All data in USD
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q4 2023 Q2Q % growth | 2.40 -11.44% | 2.11 | 0.29 | 13.87% |
Q3 2023 Q2Q % growth | 2.16 -40.00% | 2.11 | 0.05 | 2.59% |
Q2 2023 Q2Q % growth | 1.84 -52.94% | 1.97 | -0.13 | -6.45% |
Q1 2023 Q2Q % growth | 2.38 -27.22% | 2.07 | 0.31 | 14.90% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q4 2023 Q2Q % growth | 14.729B -20.63% | 16.101B | -1.372B | -8.52% |
Q3 2023 Q2Q % growth | 14.25B -32.18% | 15.218B | -968M | -6.36% |
Q2 2023 Q2Q % growth | 12.351B -41.63% | 13.813B | -1.462B | -10.58% |
Q1 2023 Q2Q % growth | 14.811B -16.61% | 15.901B | -1.09B | -6.85% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | 3.46% | -22.57% | 2.39% | -17.93% |
Revenue | 0.19% | -8.9% | -0.32% | -7.89% |